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Dorte L Egeberg1,2, Mette Lethan1, Robert Manguso1, Linda Schneider1, Aashir Awan1, Tue S Jørgensen1,
Anne G Byskov2, Lotte B Pedersen1 and Søren T Christensen1*Abstract
Background: Ovarian cancer is the fourth leading cause of cancer-related deaths among women in Denmark,
largely due to the advanced stage at diagnosis in most patients. Approximately 90% of ovarian cancers originate
from the single-layered ovarian surface epithelium (OSE). Defects in the primary cilium, a solitary sensory organelle
in most cells types including OSE, were recently implicated in tumorigenesis, mainly due to deregulation of ciliary
signaling pathways such as Hedgehog (Hh) signaling. However, a possible link between primary cilia and epithelial
ovarian cancer has not previously been investigated.
Methods: The presence of primary cilia was analyzed in sections of fixed human ovarian tissue as well as in
cultures of normal human ovarian surface epithelium (OSE) cells and two human OSE-derived cancer cell lines. We
also used immunofluorescence microscopy, western blotting, RT-PCR and siRNA to investigate ciliary signaling
pathways in these cells.
Results: We show that ovarian cancer cells display significantly reduced numbers of primary cilia. The reduction in
ciliation frequency in these cells was not due to a failure to enter growth arrest, and correlated with persistent
centrosomal localization of aurora A kinase (AURA). Further, we demonstrate that ovarian cancer cells have
deregulated Hh signaling and platelet-derived growth factor receptor alpha (PDGFRα) expression and that
promotion of ciliary formation/stability by AURA siRNA depletion decreases Hh signaling in ovarian cancer cells.
Lastly, we show that the tumor suppressor protein and negative regulator of AURA, checkpoint with forkhead-
associated and ring finger domains (CHFR), localizes to the centrosome/primary cilium axis.
Conclusions: Our results suggest that primary cilia play a role in maintaining OSE homeostasis and that the low
frequency of primary cilia in cancer OSE cells may result in part from over-expression of AURA, leading to aberrant
Hh signaling and ovarian tumorigenesis.Background
Epithelial ovarian cancer (EOC) belongs to a heteroge-
neous group of neoplasms that exhibit a wide range of
molecular defects, affecting cell survival, proliferation,
differentiation and migration. EOC is the most lethal of
the gynecologic malignancies, accounting for more than
90% of all ovarian malignancies, and is mainly a disease
of postmenopausal women [1]. The high mortality
rate of EOC is primarily due to difficulties in diagnosing
early stages of the disease. Most patients (approximately
75%) present with advanced stage (III/IV) tumors, for* Correspondence: stchristensen@bio.ku.dk
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reproduction in any medium, provided the orwhich the five-year survival rate is below 46% [1]. This is
not surprising given the size and location of the ovaries,
making them not readily accessible by pelvic examin-
ation unless significantly enlarged. Improvements in sur-
gical techniques and chemotherapy regiments over the
last three decades have resulted in improvements in
ovarian cancer treatment; however, despite these
advances most patients treated for EOC eventually de-
velop disease recurrence [2,3].
The etiology behind EOC is poorly understood, al-
though invagination clefts and inclusion cysts lined with
ovarian surface epithelium (OSE) have been pointed out
as hot spots for initiation of neoplastic processes in EOC
[4-6]. Further, a number of recent studies have indicated
that EOC is linked to aberrant cell signaling, includingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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signaling as well as over-expression of aurora A kinase
(AURA) and deregulated expression of the novel tumor
suppressor protein, checkpoint with forkhead-associated
and ring finger domains (CHFR) [7-19]. Consequently,
targeted agents against Hh pathway components, PDGFR
and AURA have been explored recently in the manage-
ment of ovarian cancer and recurrent disease [20].
Hh signaling regulates cell proliferation and differenti-
ation in numerous tissues during embryonic and fetal
development and remains active in the adult body where
it is involved in the maintenance of stem cell popula-
tions [21-23]. Hh signaling depends on a fine-tuned
intracellular signal mediated by the repressor or activa-
tor forms of the transcription factors GLI2 and GLI3,
and is mainly based on a positive feedback loop via GLI1
and a negative feedback loop via Patched-1 (PTCH1)
transcription [24,25]. It is, in particular, these feedback
loops that are found disturbed in EOC specimens [7-10].
PDGFR signaling regulates cell growth and sur-
vival, transformation, migration and wound healing
[26]. Several reports document a change in the
expression level of the alpha form of PDGFR
(PDGFRα) compared to normal OSE cells and that
this expression is associated with high tumor
grade, high proliferation index, and poor survival
rate [11-14].
AURA is a major mitotic kinase involved in centro-
some maturation, mitotic entry, and spindle assembly
[27]. AURA maps to a chromosomal region frequently
shown to be amplified in human ovarian cancer
[15,16,18], and several studies have identified elevated
AURA kinase activity and/or increased protein level as
common characteristics in ovarian cancer [15-17,28].
CHFR is a novel player in the genesis and progression
of EOC [19]. CHFR has multiple functions in check-
points during mitosis, such as regulation of the G2/M
transition by its inherent ubiquitin ligase activity and
targeting of key proteins, such as AURA, to the prote-
asome [29-32]. Nevertheless, a better understanding of
the multiple signaling pathways associated with ovarian
tumorigenesis is needed in order to identify new ways to
target signaling pathways in EOC and in this way in-
crease the efficiency of ovarian cancer treatment and
minimize recurrent disease.
Recent research showed that primary cilia may play a
critical role in tumorigenesis and cancer progression by
functioning as a tumor suppressor organelle that regu-
lates cell proliferation, differentiation, polarity, and mi-
gration [33,34]. Primary cilia are microtubule-based
organelles emanating from the distal end of the mother
centriole located beneath the plasma membrane during
growth-arrest [35]. Reception and transduction by the
cilium of chemical and mechanical signals from theextracellular environment is made possible by specific
receptors and ion channels located in or near the ciliary
membrane. Here signaling pathways regulated by recep-
tor tyrosine kinases, G-protein-coupled receptors, notch
receptors, receptors for extracellular matrix proteins and
TRP ion channels, including Hh, Wnt and PDGFRα sig-
naling [35-39], are coordinated. The functional import-
ance of the primary cilium is reflected by a number of
severe genetic diseases and developmental disorders
caused by dysfunction of cilia, commonly referred to as
ciliopathies [40,41]. Recent studies have associated some
cancers with loss of primary cilia resulting in deregu-
lated cell proliferation, and others with deregulated cil-
iary signaling [42-49]. As an example, Wong et al. [46]
demonstrated a role of the primary cilium as an import-
ant modulator of Hh signaling in basal cell carcinoma
development. They showed that loss of primary cilia in
mouse skin cells with a constitutive active Gli2 acceler-
ated tumorigenesis due to disruption in Gli2/Gli3 pro-
cessing, leading to an altered Gli2 activator/Gli3
repressor ratio . Furthermore, over-expression of an acti-
vated form of GLI2 was shown to activate Hh target
genes in two prostate cancer cell lines without primary
cilia, while over-expression of an activated form of
Smoothened (SMO) was not [47,50]. Cilium resorption
can occur as a physiological consequence of cell cycle
progression, but, as outlined above, any alteration in
physiological ciliary formation or function can have dis-
astrous effects. Interestingly, AURA, which is found to
be highly over-expressed in a variety of human cancers
[18,51-53], was recently proposed to regulate disassem-
bly of primary cilia upon mitogenic stimulation [54].
The proposed molecular mechanism includes co-
localization of AURA and the scaffolding protein HEF1
at the ciliary basal body and subsequent phosphorylation
and activation of the tubulin deacetylase HDAC6, lead-
ing to destabilization and resorption of the ciliary axo-
neme [54]. Although AURA is frequently over-expressed
or deregulated in human ovarian cancer cells [15-18,28],
it is unknown whether this correlates with defective pri-
mary cilia in these cells.
In this report, we investigated the occurrence of func-
tional primary cilia in growth-arrested normal human
OSE cells and two different human ovarian adenocarcin-
oma cell lines (SK-OV3 and OVCAR3; referred to in the
text as cancer OSE cell lines) with the focus on the cor-
relation between centrosomal AURA levels and the pres-
ence or absence of cilia and cilia-related signaling
pathways. We show that the majority (>60%) of normal
growth-arrested OSE cells display primary cilia with
PDGFRα and Hh signaling components. In contrast, the
fraction of growth-arrested cancer OSE cells with pri-
mary cilia was less than 20%, and these cells displayed
aberrant Hh signaling and down-regulated expression
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AURA is up-regulated in cancer OSE cells and that
RNAi-induced depletion of AURA in these cells leads to
a modest, but significant, increase in the number of cili-
ated cells and partial restoration of Hh signaling. Finally,
we show that CHFR localizes to the ciliary basal body in
OSE cells. These results suggest that primary cilia play a
role in maintaining OSE homeostasis and that the low
frequency of primary cilia in cancer OSE cells may result
in part from over-expression of AURA, leading to aber-
rant Hh signaling and ovarian tumorigenesis.
Results
Characterization and isolation of human OSE cells in
cultures
To study a potential link between ovarian cancer and de-
fective primary cilia, we first used immunohistochemis-
try (IHC) to characterize primary cilia in OSE cells
of tissue sections from healthy human ovaries (see
Methods for details). Consistent with previous observa-
tions [55], we found that OSE is a one-layered epithe-
lium of squamous to cuboidal cells resting on a basalFigure 1 Characterization of ovarian surface epithelium. A) Section thr
cells at top as a single layer, separated from the underlying stroma by a ba
magnification, and primary cilia (arrows) on OSE cells visualized by IFM ana
detyrosinated α-tubulin (Glu.tub). B-D) IHC analysis of ovarian tissue. OSE c
cytokeratin 8 (CK8) and cytokeratin 18 (CK18), and for the mesenchymal m
Nuclei are visualized with DAPI. DAPI, 4',6-diamidino-2-phenylindole; IFM, im
ovarian surface epithelium.membrane covering the ovaries (Figure 1A). OSE cells
possess primary cilia, as visualized with antibodies
against two well-characterized ciliary markers, acetylated
α-tubulin (Acet.tub) and detyrosinated α-tubulin (Glu.
tub) (Figure 1A, lower insert) as described earlier [56].
Further, consistent with previous observations [57-59],
we found that OSE has a limited commitment to the
epithelial phenotype indicated by the retention of mes-
enchymal features, such as expression of vimentin and
N-cadherin, and it lacks some of the typical epithelial
characteristics, such as E-cadherin (Figure 1B-D).
The active engagement of OSE cells in tissue repair is
in keeping with the dual epithelial-mesenchymal pheno-
type or uncommitted phenotype, characterized by co-
expression of cytokeratins and vimentin (Figure 1B-D),
which likely confers advantages during the postovulatory
repair of the ovarian surface in vivo. Furthermore, OSE
differs from other epithelia by its tenuous attachment to
its basement membrane, from which it is easily detached
by mechanical means [60]. We exploited this feature of
OSE to establish primary cell cultures of OSE cells by
gentle scraping of the ovarian surface. We refer to theseough a normal adult ovarian cortex stained with H & E, showing OSE
sal membrane (dotted line). The inserts show OSE cells in higher
lysis with antibodies against acetylated α-tubulin (Acet.tub) and
ells are characterized by being positive for the epithelial markers
arkers N-cadherin and vimentin, whereas they are E-cadherin negative.
munofluorescence microscopy; IHC, immunohistochemistry; OSE,
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scope wt OSE cells appear almost cubic and are orga-
nized in a regular pavement with close intercellular
apposition and no overlap in the confluent stage
(Figure 2A). We also analyzed cultures of SK-OV3 and
OVCAR3, which are well-described human ovarian
adenocarcinoma cell lines [61,62] often used as experi-
mental models for EOC. In line with the heterogeneity
of ovarian neoplasms, the morphologies of the two can-
cer OSE cell lines are very unlike each other; OVCAR3
forms a cobblestone-like monolayer with foci of multi-
layering at high cell densities. In the subconfluent stage,
the cells grow in small colonies separated by void spaces,
which over time become sparse due to expansion of the
colonies. OVCAR3 cells are epithelial in morphology,
whereas SK-OV3 cells are atypical and more fibroblast-
like with long and slender cells. In the confluent stage,
SK-OV3 cells form a monolayer with a more disordered
appearance compared to the wt OSE and OVCAR3 cells
(Figure 2A). Even though the morphologies of the two
cancer OSE cell lines differ they are both of epithelial
origin [62,63].
We next characterized the wt and cancer OSE cell
lines using antibodies specific for different cytoskeletalFigure 2 Characterization of cell cultures of ovarian surface epithelium
cultures at sub-confluent and confluent stages. Anti-α-tubulin (α-tub) and p
microtubules and actin, respectively, by IFM analysis, and anti-cytokeratin 8
keratin components characteristic of human OSE cells. B) IFM analysis with
cancer OSE cells. See text for details. DNA was stained with DAPI. C) WB of
characteristic for human OSE cells. EB1 was applied as loading control. DAP
OSE, ovarian surface epithelium; WB, western blot; wt, wild type.proteins and OSE markers in immunofluorescence mi-
croscopy (IFM) and western blot (WB) analysis. Consist-
ent with IHC analysis of OSE in ovarian tissue sections
(Figure 1B-D), cultured wt OSE cells were positive for
cytokeratin-8 and −18 (CK8 and CK18) as well as
vimentin and N-cadherin, and negative for E-cadherin
(Figure 2A-C). In contrast, only a very few CK8 and
CK18 positive cells were observed in the SK-OV3 cell
line, whereas OVCAR3 cells were positive for both.
However, OVCAR3 cells were negative to vimentin
staining. Furthermore, both cancer cell lines expressed
E-cadherin, which localized to the cell borders, whereas
anti-N-cadherin stained a punctuated material within
the cells (Figure 2A-C). These findings correlate well
with previous reports indicating that ovarian cancer cells
display a more classical epithelial phenotype compared
to normal OSE cells [59,64,65].
Reduced frequency of primary cilia in cultures of human
cancer OSE cells
Primary cilia emerge from OSE cells in tissue sections of
mouse and human ovaries [56], but the function of these
cilia remains to be investigated (Figure 1A). To address
this we first investigated the occurrence of primary cilia. A) Light microscopy (LM) images of wt and cancer OSE cells in
halloidin (F-actin) were applied to vizualize the cytoskeletal
(CK8) and anti-cytokeratin 18 (CK18) were applied to visualize the
primary antibodies against markers differentially expressed in wt and
wt and cancer OSE cells showing their expression of proteins
I, 4′,6-diamidino-2-phenylindole; IFM, immunofluorescence microscopy;
Egeberg et al. Cilia 2012, 1:15 Page 5 of 17
http://www.ciliajournal.com/content/1/1/15in cultures of wt and cancer OSE cells using IFM with
antibodies against ciliary (Acet.tub, Glu.tub) and centro-
somal (pericentrin, centrin) markers. IFM was per-
formed on sub-confluent cultures grown in the presence
of serum (0 hour) and in confluent cultures that had
been serum-starved for 48 or 72 hours to induce forma-
tion of primary cilia, and the number of ciliated cells for
each growth condition was quantified (Figure 3A-C).
The results show that both wt and cancer OSE cells pos-
sess primary cilia and that serum depletion increases the
frequency of ciliated cells in the cultures (Figure 3C).
However, both cancer OSE cultures have significantly
fewer ciliated cells compared to wt OSE cultures, even
after 72 hours of serum starvation (Figure 3C).
Construction of the ciliary axoneme requires intrafla-
gellar transport (IFT), a bidirectional transport system
driven by motor protein complexes that bring axonemalFigure 3 Characterization of primary cilia formation in OSE cell cultur
followed by serum depletion for 72 hours to induce growth arrest and form
were detected with anti-acetylated α-tubulin (Acet.tub) and anti-detyrosina
of the centrosome and the centrioles were visualized with anti-pericentrin
frequencies were determined, by IFM analysis with anti-Acet.tub and/or an
number in sub-confluent cultures in the presence of serum (0 hour) and in
represent standard deviations. Data were tested for significance using one-
Localization of IFT20 and IFT88 was visualized by IFM in serum-depleted w
and IFT20 in wt and cancer OSE cells in sub-confluent cultures with serum
hours. α-Tubulin (α-tub) was applied as loading control. ANOVA, analysis of
immunofluorescence microscopy; OSE, ovarian surface epithelium; WB, wesprecursors to the growing tip of the cilium and return
turnover products to the base [66]. Since IFT20 and
IFT88 are required for effective ciliogenesis [67-69], we
assessed the sub-cellular localization and expression of
these proteins in the wt and OSE cell cultures grown in
the presence or absence of serum. Similar to findings in
other cell types [67-69], IFT20 was localized at the Golgi
apparatus and IFT88 at the base and tip of primary cilia
in wt OSE cells (Figure 3D). Further, WB analysis of
lysates from wt and cancer OSE cell cultures grown with
or without serum demonstrated that IFT88 and IFT20
are expressed at similar levels in all three OSE cell lines
(Figure 3E). Thus the reduced frequency of ciliated cells
in cancer OSE cells is unlikely to result from lack of
these IFT proteins.
Primary cilia are normally absent in rapidly prolife-
rating cells due to their resorption during cell cyclees. Wild type (wt) and cancer OSE cells were grown to confluence
ation of primary cilia (arrows). Microtubules of the ciliary axoneme
ted α-tubulin (Glu.tub) in IFM analysis (A, B). The pericentriolar material
(PCTN) and anti-centrin (CT) antibodies, respectively. C) Cilia
ti-Glu.tub, antibodies, as the number of ciliated cells over the total cell
confluent cultures serum-depleted for 48 or 72 hours. Error bars
way ANOVA. The level of significance was set at P< 0.001 (***). D)
t OSE cultures. Nuclei were stained with DAPI. E) WB analysis of IFT88
(0 hour) and confluent cultures depleted for serum for six, 24, or 72
variance; DAPI, 4′,6-diamidino-2-phenylindole; IFM,
tern blot; wt, wild type.
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the low frequency of primary cilia in cancer OSE cells
results from a high rate of proliferation. To address this,
we analyzed the wt and cancer OSE cells by WB and
IFM using antibodies against known cell proliferation
markers. As shown in Figure 4A-D, wt OSE cells are
able to enter growth arrest after 72 hours of serum de-
pletion, as indicated by an approximate 12-fold reduc-
tion in the level of phosphorylated retinoblastoma
protein (p-RB) and an approximate 17-fold reduction in
the level of proliferating cell nuclear antigen (PCNA).
Similar results were obtained for SK-OV3 cells whereas
the reductions in p-RB and PCNA levels in OVCAR3
cells were slightly less prominent with reductions of
about six-fold and 11-fold, respectively (Figure 4A-D).
IFM analysis with Ki67 antibody confirmed that both wt
OSE and SK-OV3 cells are able to enter growth arrest
upon serum depletion (Figure 4E, F), whereas the ability
of the OVCAR3 cells to enter growth arrest seems to be
slightly compromised (Figure 4G). Taken together, ourFigure 4 wt and cancer OSE cells enter growth arrest upon serum de
with serum (0 hour) and confluent cultures serum depleted for 48 and/or 7
phosphorylated retinoblastoma protein (p-RB) in wt and cancer OSE cells a
cultures with serum and with respect to the loading controls (β-actin). C, D
antigen (PCNA) in wt and cancer OSE cells and quantification of PCNA leve
respect to the loading controls (α-tub). E-G) IFM analysis of wt and cancer
primary cilia (arrows), and anti-Ki67 antibody to visualize Ki67 expression of
cells enter growth arrest upon serum starvation, as judged by the lack of n
immunofluorescence microscopy; OSE, ovarian surface epithelium; WB, wesresults (Figures 3 and 4) indicate that the majority of
growth-arrested wt OSE cells possess primary cilia,
whereas the majority of growth-arrested cancer OSE
cells do not. The results further suggest that the reduced
frequency of primary cilia in cancer OSE cells is not pri-
marily due to the inability of these cells to enter growth
arrest.
Hedgehog and PDGFRα signaling are associated with OSE
primary cilia and are disrupted in cancer OSE cells
As described in the Background, Hh and PDGFR signal-
ing have both been associated with ovarian tumorigen-
esis. Since Hh signaling components and PDGFRα
localize to primary cilia in a variety of cell types [37], we
investigated if primary cilia are associated with Hh and
PDGFRα signaling in wt and cancer OSE cells. IFM ana-
lysis with antibodies against different Hh components
showed that GLI2, SMO and PTCH1 localize to primary
cilia in wt OSE cells (Figure 5A). Since processing of the
full-length GLI2 (activator form) to the repressor form ispletion. Analysis of known cell cycle markers in sub-confluent cultures
2 hours. A, B) WB analysis showing protein expression of
nd quantification of p-RB levels in serum depleted cultures relative to
) WB analysis showing protein expression of proliferating cell nuclear
ls in serum depleted cultures relative to cultures with serum and with
OSE cells using anti-acetylated α-tubulin (Acet.tub) antibody to detect
cycling cells. Nuclei were visualized with DAPI. Note that most cancer
uclear Ki67 staining. DAPI, 4′,6-diamidino-2-phenylindole; IFM,
tern blot; wt, wild type.
Figure 5 Hedgehog components and PDGFRα localize to OSE primary cilia. IFM analysis of serum-starved wt OSE cells using antibodies
against the Hh components GLI2, SMO, and PTCH1 (A), or PDGFRα (D). Primary cilia (arrows) were detected with anti-acetylated α-tubulin (Acet.
tub) antibody. B) WB analysis of wt and cancer OSE cells grown in the presence (0 hour) and or absence (72 hours) of serum. Blots were probed
with antibodies against the full-length activator form of GLI2, GLI2(FL), or the C-terminally processed repressor form of GLI2, GLI(R). α-tubulin (α-
tub) was applied as loading control. C) RT-PCR showing the expression level of the Hh responsive genes PTCH1 and GLI1 in cultures of wt and
cancer OSE cells serum depleted for 72 hours. GAPDH was applied as an internal control. E) WB analysis of wt and cancer OSE cells grown in the
presence (0 hour) or absence (72 hours) of serum. The PDGFRα antibody used recognizes two protein bands; #1 is the fully glycosylated form and
#2 is the partly glycosylated form of the receptor. α-tub was applied as loading control. IFM, immunofluorescence microscopy; Hh, hedgehog;
OSE, ovarian surface epithelium; WB, western blot; wt, wild type.
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GLI2 processing in wt and cancer OSE cells. WB ana-
lysis showed that wt OSE cells grown in the presence or
absence of serum contain no or very little full-length
GLI2 (activator) under either culture condition, whereas
the processed repressor form of GLI2, GLI2(R), is
present (Figure 5B). In contrast, sub-confluent, non-
starved cultures (0 hour) of both cancer OSE cell lines
contained a higher level of full-length and a much lower
level of the GLI2 repressor form compared to wt OSE
cells (Figure 5B). After 72 hours of serum starvation, the
level of full-length GLI2 decreased in the OSE cancer
cell lines and the level of repressor GLI2 increased, but
not to levels comparable to those of wt OSE cells
(Figure 5B). Consistent with these results, RT-PCR ana-
lysis in serum-starved cultures demonstrated that even
in the absence of added Hh ligands to the medium,
the SK-OV3 cells have a higher basal transcription of
Hh responsive genes (PTCH1, GLI1) compared to wt
OSE cells, whereas OVCAR3 only has a higher basal
transcription of PTCH1 (Figure 5C). The differentexpression patterns of Hh target genes in ovarian can-
cer cell lines might reflect the heterogeneity of ovarian
neoplasms as postulated by others (see above). Thus,
the cancer OSE cells display increased basal expression
of Hh responsive genes.
We next investigated the localization and expression of
PDGFRα in OSE cultures by IFM and WB analysis.
PDGFRα was previously shown to be up-regulated dur-
ing growth arrest [73] and to localize to primary cilia in
fibroblasts [74,75] and other cell types [36]. However, cil-
iary localization of PDGFRα has not previously been
reported for OSE cells. As shown in Figure 5D, we found
that PDGFRα localizes to primary cilia of wt OSE cells
and PDGFRα is up-regulated during growth arrest in
these cells (Figure 5E). In contrast, SK-OV3 and
OVCAR3 cells display a markedly lower level of PDGFRα
protein and no increase in PDGFRα level is observed
upon serum depletion in these cell lines (Figure 5E). As
described elsewhere [74], the PDGFRα antibody used
recognizes two protein bands in WB analysis; a high-
molecular weight protein band representing the mature
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protein band representing the immature and only partly
glycosylated form of the receptor. Notice that in OVCAR3
cells only the low-molecular weight form of the receptor
(#2) is detectable in WB analysis (Figure 5E). These data
indicate that PDGFRα signaling via primary cilia during
growth arrest likely is perturbed in cancer OSE cells, al-
though this requires further investigations.The level of aurora A kinase is reduced at the ciliary base
in normal OSE cells and up-regulated in cancer OSE cells
with defective primary cilia
AURA has been implicated in cilia disassembly in
Chlamydomonas [76] and mammalian cells [54]. This
protein is often over-expressed in ovarian cancer cells.
Therefore, we speculated whether the reduced frequency
of ciliated cells observed in cancer OSE cells (Figure 3C)
is linked to altered protein level and/or localization of
AURA compared to wt OSE cells. To investigate this we
analyzed the localization and expression of AURA in
OSE cells by IFM, RT-PCR and WB. During mitosis,
AURA displayed a centrosomal localization in both wt
and cancer OSE cells (Figure 6A), consistent with previ-
ous reports [77]. Upon induction of growth arrest by
serum depletion, the expression level of AURA was
decreased dramatically in wt OSE cells, both at the
mRNA (Figure 6B) and protein level (Figure 6C). AURA
levels in serum-depleted SK-OV3 cells were reduced
compared to non-starved cells but not to the same ex-
tent as serum-starved wt OSE cells. In contrast, AURA
levels in serum-depleted OVCAR3 cells were largely
similar to those of non-starved cells and significantly
higher than those of starved wt OSE cells (Figure 6B, C).
The elevated cellular level of AURA in the serum-
depleted cancer OSE cells was not caused by a failure of
these cells to enter growth arrest, as judged by WB with
p-RB antibody (Figure 6C).
Consistent with the results of WB and RT-PCR ana-
lyses (Figure 6B, C), IFM analysis revealed that the cen-
trosomal pool of AURA was clearly diminished in
serum-depleted, ciliated wt OSE cells compared to
non-starved cells (Figure 6D). Similarly, we observed
that centrosomes of the few ciliated cancer OSE cells
lacked AURA (data not shown). However, in serum-
depleted SK-OV3 and OVCAR3 cells, centrosomes
(marked with anti-EB3 and anti-pericentrin) mostly
lacked primary cilia (stained with anti-Acet.tub) and
were clearly AURA positive (Figure 6E; see also
Figure 3C). The over-expression and localization of
AURA to centrosomes in growth-arrested cancer OSE
cells suggest that AURA may play a role in suppressing
ciliogenesis and/or promoting ciliary disassembly in
cancer OSE cells.The tumor suppressor protein, CHFR, localizes to the base
of OSE primary cilia
In the mouse, the tumor suppressor protein, Chfr, is
known to inhibit AurA by ubiquitination and proteaso-
mal degradation [32]. The potential involvement of
AURA in regulating cilia assembly or disassembly in
human OSE cells (see above) prompted us to investigate
whether CHFR is associated with the centrosome/cilium
axis in these cells. To this end, we generated a poly-
clonal rabbit antibody against human CHFR (see
Methods for details). WB analysis of lysates of cultured,
serum-starved hTERT-RPE1 or NIH3T3 cells demon-
strated that the CHFR antiserum recognizes a single
band of about 73 kDa equivalent to the predicted size of
endogenous CHFR (73.4 kDa for isoform 1) (Additional
file 1: Figure S1A, B), and by WB analysis the CHFR
antibody also recognized exogenous green fluorescent
protein (GFP)-tagged CHFR expressed stably in serum-
starved hTERT-RPE1 cells (Additional file 1: Figure
S1C). Further, both endogenous and CHFR and GFP-
tagged CHFR localized to the base of primary cilia in
serum-starved hTERT-RPE1 cells (Additional file 1:
Figure S1D, E). In serum-starved wt OSE cells the CHFR
antibody predominantly labeled the base of primary cilia,
but no clear localization of the antibody was observed in
interphase or mitotic wt OSE cells (Figure 6F). However,
in hTERT-RPE1 cells CHFR was detected at centrosomes
in growth-arrested as well as cycling cells (data not
shown), suggesting that the lack of detection of CHFR at
centrosomes of mitotic OSE cells could be due to low
abundance of the protein. These data conflict with previ-
ous studies showing that over-expressed, epitope-tagged
CHFR displays a predominantly nuclear localization [78-
80], but are in agreement with studies showing that en-
dogenous CHFR localizes to cytoplasm and centrosomes
during interphase growth [31,81,82] and to spindle poles
during mitosis [82]. This is the first report on CHFR
localization to primary cilia, and future studies might re-
veal if CHFR takes part in the signaling machinery that
regulates ciliary disassembly.
Depletion of AURA increases the frequency of primary
cilia and reduces Hh signaling in cancer OSE cells
To further explore a possible link between AURA and
lack of cilia in cancer OSE cells, we investigated whether
knockdown of AURA by siRNA affected the frequency
of ciliated SK-OV3 cells during growth arrest. Figure 7A
shows results from three successful knockdowns of
AURA, as judged by WB analysis. This analysis also
demonstrated that knockdown of AURA does not affect
the ability of cells to enter growth arrest upon 72 hours
of serum depletion, visualized by the even protein level
of p-RB in mock and AURA siRNA-treated cells
(Figure 7A, top panels). The bar graph representations
Figure 6 Aurora A localization and expression in wt and cancer OSE cells. IFM analysis of mitotic (A), interphase (D), and growth-arrested
(D, E) wt and cancer OSE cells. Anti-pericentrin (PCNT), anti-EB3, anti-acetylated α-tubulin (Acet.tub), and anti-AURA were applied to detect the
pericentriolar material (¤), centrioles (*), mitotic spindle and primary cilia (white arrows), and AURA, respectively. The rightmost column in (D) is a
shifted overlay of the Acet.tub, AURA, and EB3 stainings. Cells in A, and rightmost column in E were fixed in mix-fix (see Methods for details), and
cells in (D, E) were fixed in PFA+MeOH fix. B, C) AURA mRNA and protein levels were analyzed with RT-PCR (B) and WB (C), respectively, in sub-
confluent cells with serum (0 hour) and in confluent cultures serum-depleted for 72 hours. GAPDH (B) and EB1 (C) were used as controls. Anti-
phosphorylated retinoblastoma protein (p-RB) was included in WB analysis to verify that starved cells were in growth arrest (C). F) IFM analysis of
checkpoint with forkhead-associated and ring finger domains (CHFR) localization in wt OSE cells during mitosis and in growth-arrested, serum-
depleted cells. Cells were fixed in mix-fix and stained with antibodies as indicated. Primary cilia are marked with arrows and centrioles/basal
bodies are marked with ¤. DNA was stained with DAPI. DAPI, 4′,6-diamidino-2-phenylindole; IFM, immunofluorescence microscopy; OSE, ovarian
surface epithelium; WB, western blot; wt, wild type.
Egeberg et al. Cilia 2012, 1:15 Page 9 of 17
http://www.ciliajournal.com/content/1/1/15
Figure 7 Inhibition of Aurora A and effect on ciliary formation in cancer OSE cells. A) Results of three independent siRNA knock-down
experiments of AURA in SK-OV3 cells. Cells were grown to 60% confluency and transfected with scrambled oligonucleotides (mock) or siRNA
targeting AURA mRNA. The cells were allowed to grow to confluence and 24 hours after transfection, medium was changed to serum-depleted
medium. After 72 hours of incubation in serum-depleted medium, AURA protein levels were examined by WB analysis. Anti-phosphorylated
retinoblastoma protein (p-RB) was included to explore the cell cycle stage. EB1 was applied as loading control. Percentages of ciliated cells were
determined by IFM analysis with primary antibodies against acetylated α-tubulin, detyrosinated α-tubulin, and DAPI nuclear staining as the
number of ciliated cells over the total cell number. Error bars represent standard deviations. B) Bar graph representation of the level of ciliated SK-
OV3 cells in AURA siRNA transfected cells relative to mock transfected cells. The percentage of ciliated cells in mock transfected cells was set to
one. Data were tested for significance using Student’s t-test. The level of significance was set at P< 0.001 (***). C) Protein levels of the full length
activator form of GLI2, GLI2 (FL), acetylated α-tubulin (Acet.tub), and α-tubulin (α-tub) in mock and AURA siRNA transfected SK-OV3 cells serum-
depleted for 72 hours. D) Bar graph representation of the relative protein levels in AURA siRNA transfected SK-OV3 cells compared to mock
transfected cells. The protein level in mock transfected cells was set to one. Data were tested for significance using Student’s t-test. The effect of
AURA siRNA treatment on Acet.tub and α-tub protein levels was found to be not significant (n.s.), whereas the treatment had a significant effect
on GLI2 (FL), P< 0.01 (**). DAPI, 4‘,6-diamidino-2-phenylindole; IFM, immunofluorescence microscopy; OSE, ovarian surface epithelium; WB, western
blot.
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the three SK-OV3 cultures with and without knockdown
of AURA, quantified by IFM analysis. Taken together,
the data show a modest, but significant and about two-
fold increase in the number of ciliated cells in the
AURA-depleted cultures relative to mock-transfected
control cells (Figure 7B). Lastly, WB analysis demon-
strated that knockdown of AURA in SK-OV3 cells
results in reduced cellular level of GLI2 full-length acti-
vator (Figure 7C, D), presumably due to the higher fre-
quency of primary cilia in these cultures. In contrast,
knockdown of AURA had no detectable effect on the
level of acetylated α tubulin, suggesting that this type of
acetylation is not associated with AURA activity in OSE
cells (Figure 7C, D).Discussion
In this study, we investigated the occurrence of primary
cilia in human wt and cancer OSE cells with a focus on
the correlation between AURA and the presence or ab-
sence of primary cilia with functional Hh signaling and
expression of PDGFRα. Our results show that EOC cells
are mostly devoid of primary cilia, and we suggest that
this in part may be due to increased expression of
AURA in these cells. These findings are in agreement
with other studies on cancer cells, such as pancreatic
adenocarcinoma cells, basal cell carcinoma cells, and
clear cell renal cell carcinomas that also have reduced
frequency of primary cilia [44,46,83,84], which in some
cases can be explained by over expression of AURA [83].
However, in contrast to, for example, pancreatic cancer
Egeberg et al. Cilia 2012, 1:15 Page 11 of 17
http://www.ciliajournal.com/content/1/1/15cells that may not form cilia because the cells fail to
enter growth arrest [84], cancer OSE cells, such as SK-
OV3, enter growth arrest upon serum depletion at a
level comparable to that of wt OSE cells. The vast ma-
jority of OVCAR3 cells also entered growth arrest upon
serum depletion, although not as many as SK-OV3 cells.
Thus, lack of cilia in these cells seems not to be caused
merely by a failure of the cells to become quiescent, sug-
gesting that ovarian cancer cells have defects in the
regulatory proteins that control ciliary assembly and/or
disassembly.
How is ciliary formation perturbed in cancer OSE
cells? Initially, we investigated the expression and
localization of two IFT proteins, IFT20 and IFT88, es-
sential for the assembly of primary cilia and found no
obvious difference between normal human OSE cells
and the two ovarian cancer cell lines. In contrast, we
observed a dramatic decrease in the expression of AURA
in growth-arrested wt OSE cells compared to growth-
arrested SK-OV3 and OVCAR3 cells. Although SK-OV3
and OVCAR3 cells differ, for example in regard to
morphology and ability to enter growth arrest, both cell
lines maintained a high level of AURA at centrosomes in
cells not forming primary cilia. Since AURA has been
implicated in ciliary disassembly [54], we suggest that
high levels of AURA at the centrosomal region suppress
ciliary formation and/or promote ciliary disassembly in
growth-arrested cancer OSE cells. This may have dire
consequences for regulation of signaling pathways that
are coordinated by primary cilia such as Hh and
PDGFRα signaling,which, when aberrantly regulated, are
associated with EOC [7-14]. Indeed, we here show that
PDGFRα and essential components of the Hh pathway,
including SMO, PTCH1 and GLI2, localize to primary
cilia of wt OSE cells and that cancer OSE cells display
increased basal expression of Hh responsive genes. Fur-
ther, in cancer OSE cells, there is a defect in expression
and/or glycosylation of PDGFRα, in that SK-OV3 cells
are not up-regulating PDGFRα expression during growth
arrest, and that both up-regulation and glycosylation of
the receptor is hampered in OVCAR3 cells. Previously,
up-regulation of PDGFRα during growth arrest was
shown to be blocked in Tg737orpk mouse embryonic
fibroblasts, which have a hypomorphic mutation in
IFT88 and, therefore, form no or very short primary cilia
[74]. We suggest that defects in ciliary formation due to
over-expression and centrosomal localization of AURA
in cancer OSE cells in a similar way may perturb proper
Hh signaling as well as PDGFRα expression and function
leading to homeostatic imbalance of the ovarian surface
epithelium.
In order to investigate AURA function in the forma-
tion of primary cilia in more detail, we conducted siRNA
knockdown of AURA in growth-arrested SK-OV3 cells,since these cells entered growth arrest upon serum de-
pletion at a level comparable to that of wt OSE cells.
AURA knockdown increased the number of ciliated can-
cer OSE cells albeit to a small, but significant, extent,
and this was accompanied by a lower level of the full-
length activator form of the GLI2 protein, involved in
Hh signaling. These results are similar to previous
results reported for, for example, renal cancer cells that
lack the von Hippel-Lindau tumor suppressor protein; in
these cells, it was shown that siRNA-mediated inhibition
of the HEF1-AURA pathway caused a significant in-
crease in the frequency of ciliated cells, whereas over ex-
pression of AURA or HEF1 in control renal cells
promoted cilia loss [83]. Thus over-expression of AURA
and loss of primary cilia may be a common characteris-
tic of several types of cancers, in which a moderate res-
toration of ciliary formation is associated in part with a
reduction in aberrant Hh signaling. The fact that AURA
siRNA did not fully restore ciliary formation in cancer
OSE cells, suggests that the cells were not completely
depleted for AURA and/or that the function of other
regulatory proteins in ciliary assembly and maintenance
is disrupted.
A number of proteins have been suggested to play a
role in regulating AURA activity and/or expression. A
prominent example is the tumor suppressor protein,
CHFR, which has been implicated in multiple human
cancers, including EOC [19,85,86]. Originally, CHFR was
shown to function as a mitotic checkpoint protein
required for tumor suppression, partly through ubiquiti-
nation and targeting of AURA for degradation in the
proteasome [31,32,87]. In concurrence with previous
findings that CHFR localizes at centrosomes in inter-
phase cells [81] and at spindle poles in mitotic cells [82],
we found that CHFR localizes to the centrosomal region
at the base of primary cilia and in some cases along the
length of the cilium in growth-arrested OSE and RPE
cells. This is the first report on the localization of this
tumor suppressor protein to primary cilia, and although
speculative at this point, we suggest that CHFR may
function at the cilium to promote cilia stability through
inactivation of AURA.
Several proteins are known to interact with AURA
during mitosis, but AURA partners and downstream tar-
gets at other cell cycle stages are less investigated. In a
seminal work by Pugacheva et al. [54] it was shown that
ciliary disassembly in RPE cells is in part coordinated by
AURA-mediated activation of HDAC6, a tubulin deace-
tylase that promotes destabilization of microtubules [88-
90]. In contrast, Sharma et al. [91] used the same cell
type to show that inhibition of HDAC6 followed by
increased level of microtubule acetylation did not affect
cilia stability in concurrence with the findings that
HDAC6-deficient mice are viable and have no
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Similarly, we find that knockdown of AURA by siRNA
did not affect the overall level of acetylated tubulin as
judged by WB analysis, suggesting that tubulin deacety-
lase(s) is not the major target for AURA-induced ciliary
disassembly or inhibition of ciliary assembly in OSE
cells.
Conclusions
In this work we have established a new platform from
which to investigate cellular processes and signaling
pathways in ovarian cancer using primary cultures of
human OSE cells as well as cultures of human ovarian
cancer cell lines. We show that EOC, which comprises
the vast majority of human ovarian cancers, is associated
with defects in formation of primary cilia that control
signaling pathways in ovarian homeostasis such as Hh
and PDGFRα signaling. We also show that reduced fre-
quency of primary cilia in cancer cells correlates with
overexpression of AURA and persistent localization of
AURA to the centrosome in growth arrested cells devoid
of primary cilia. We further show that the tumor sup-
pressor protein, CHFR, which inactivates AURA and
when mutated or expressed at low levels causes ovarian
tumorigenesis, is a centrosomal protein that localizes to
the ciliary base in growth arrested wt OSE cells. Future
analysis should focus on how CHFR and AURA interact
at the primary cilium to control downstream targets in
ciliary assembly, disassembly and function.
Methods
Collection of human ovaries and tissue sectioning
Healthy human ovaries were sent to the Laboratory of
Reproductive Biology at the University Hospital of
Copenhagen for cryopreservation (Cryopreservation of
ovarian tissue has been approved by the Minister of
Health in Denmark and by the ethical committee of the
municipalities of Copenhagen and Frederiksberg, journal
number KF/01/170/99) from women about to initiate
chemotherapy for malignancies other than ovarian can-
cer. Tissue specimens were dissected into appropriate
tissue blocks and fixed for 12 to 24 hours at 4°C in
Bouin’s fixatives. The specimens were dehydrated with
graded alcohols, cleared in xylene, and embedded in par-
affin wax. Serial sections, 5 μm thick, were cut and
placed on silanized glass slides. Representative sections
of each series were stained with H & E.
Cell cultures
OSE cells were obtained by scraping the surface of
the ovaries with a surgical blade as described elsewhere
[60]. The cells were collected in Iscove’s modified Dul-
becco’s medium (Invitrogen, Taastrup, Denmark) with
1% penicillin-streptomycin (Invitrogen), immediatelyfollowed by centrifugation at 300 x g for five minutes
at room temperature. The cell pellet was resuspended in
OSE growth medium (Minimum Essential Medium α-
medium [Invitrogen], 15% fetal bovine serum [FBS; Invitro-
gen], 1% Glutamax™-1 [Invitrogen], 1% Minimum Essential
Medium non-essential amino acids solution [Invitrogen], 1%
insulin-transferrin-selenium supplement [Invitrogen], 1%
penicillin-streptomycin, and 3.3 mU/ml follicle-stimulating
hormone/luteinizing hormone (Menopur, Ferring, Kiel,
Germany), and placed in a 35-mm culture dish coated
with 0.1% gelatin (Sigma, St. Louis, Missouri, USA).
The cultures were incubated at 37°C in 5% CO2 in
air and left undisturbed for at least 48 hours.
Medium was changed at intervals of two to three
days. The ovarian cancer cell lines OVCAR3 (ATCC-
HTB-161) and SK-OV3 (ATCC-HTB-77) were pur-
chased from the American Type Culture Collection
(Manassas, Virginia, USA). The cancer cell lines were
cultured in OSE growth medium on a gelatin coating
as described above. Passing of cells was performed by
trypsination. The cell lines were maintained by passa-
ging continuously on a weekly basis. Cells were exam-
ined at a sub-confluent stage in the presence of
serum (0 hour or interphase cells) or at confluency
followed by serum starvation for indicated time peri-
ods to induce growth arrest.
Culture, transfection, and selection of stable hTERT-
RPE1 cells expressing GFP-CHFR was performed essen-
tially as described [93]. For generation of GFP-CHFR
expressing cells, plasmid pEGFP-C1 (Clontech, Mountain
View, California, USA) containing full-length CHFR cod-
ing sequence (kind gift from Kenneth B. Schou, Danish
Cancer Society, Copenhagen, Denmark) was used. The
culture of NIH3T3 cells was done as described previously
[74].
Immunohistochemical (IHC) analysis
Tissue sections were dewaxed, rehydrated and washed in
PBS as previously described [56], followed by rinsing
with blocking buffer (5% BSA in PBS) for 15 minutes be-
fore incubation with primary antibodies overnight at
4°C. See Table 1 for applied primary antibodies in IHC
analysis. The sections were then washed three times in
blocking buffer, incubated for 45 minutes in dark with
fluorochrome-conjugated secondary antibodies (Alexa
Flour 488 and Alexa Flour 568, Invitrogen) diluted 1:600
in blocking buffer,and, after a wash in blocking buffer,
briefly incubated with DAPI (Invitrogen, 1:600) in block-
ing buffer. After washing in PBS, sections were mounted
in anti-fade mounting solution (80% glycerol and 2%
N-propylgallate in PBS), covered with a glass slide
and sealed with nail polish. Differential interference
contrast microscopy (DIC) and fluorescence microscopy
analysis were carried out with a Nikon Eclipse E600 and
Table 1 Primary antibodies applied in this study
Antigen IgG Source IHC IFM WB
Acetylated α-tubulin mMouse Sigma 1:1000 1:5000 1:2500
Aurora A/AlK (1 G4) mRabbit Cell Signaling 1:100 1:200
Centrin-2 (N-17) pGoat Santa Cruz 1:500
CHFR pRabbit This study 1:500 1:10.000
Cytokeratin-8 (M-20) mMouse Santa Cruz 1:100 1:100
Cytokeratin-18 mRabbit Epitomics 1:100 1:100 1:1500
Detyrosinated α-tubulin pRabbit Abcam 1:800 1:800
EB1 (KT51) mRat Absea 1:1000
EB3 (KT36) mRat Absea 1:200
E-cadherin pRabbit Cell Signaling 1:25 1:25 1:200
GFP mMouse Abcam 1:200 1:1000
IFT20 pRabbit kind gift from Greg Pazour 1:1000 1:1000
IFT88 pRabbit kind gift from Greg Pazour 1:1000 1:1000
Ki67 pRabbit Abcam 1:500
N-cadherin pRabbit Abcam 1:200 1:200 1:800
Patched-1 pGoat Santa Cruz 1:200
PCNA (PC10) mMouse Cell Signaling 1:2000
Pericentrin (C-16) pGoat Santa Cruz 1:200
Phospho-RB (Ser807/811) pRabbit Cell Signaling 1:200
Smoothened pRabbit Abcam 1:100
GLI2 (G-20) pGoat Santa Cruz 1:200
GLI2 (H-300) pRabbit Santa Cruz 1:100
Vimentin mMouse Abcam 1:100 1:100 1:500
α-tubulin mMouse Sigma 1:500 1:2000
β-actin mMouse Sigma 1:10.000
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performed using an Optronics MagnaFire CCD camera
and Olympus DP72 color CCD camera. The images were
processed for publication in Adobe Photoshop version
6.0.
IFM, immunofluorescence microscopy; IgG,
immunoglobulin G; IHC, immunohistochemistry; WB,
western blot
Immunofluoresence microscopy (IFM) analysis
Cells were grown on 12-mm sterile HCl-cleansed cover-
slips coated with 0.1% gelatin. The coverslips were
washed in ice cold PBS and fixed with either 4% parafor-
maldehyde (PFA; PFA-fix), 4% PFA and methanol (PFA+
MeOH-fix) or with 3% PFA in Brinkley Reassembly
Buffer 80 (and methanol (mix-fix). For PFA-fix, cells
were fixed for 15 minutes at room temperature, washed
twice in PBS, and then permeabilized with 0.2% Triton
X-100 and 1% BSA in PBS for 12 minutes. For PFA+
MeOH-fix, cells were first fixed with 4% PFA for 10
minutes, washed twice in PBS, and fixed again for 5minutes in ice-cold methanol. After removal of the
methanol, the coverslips were allowed to air dry for a
short period followed by permeabilization with 0.2% Tri-
ton X-100 and 1% BSA in PBS for 12 minutes. For mix-
fix, cells were fixed with 3% PFA in Brinkley Reassembly
Buffer 80 (80 mM PIPES pH 6.9, 1 mM EGTA, 1 mM
MgCl2) for two minutes, washed in ice cold PBS, and
fixed again for two minutes in ice-cold methanol. After
removal of the methanol, the coverslips were allowed to
air dry for a short period followed by rehydration in
PBS. To avoid unspecific antibody binding, coverslips
(all kinds of fixation and permeabilization) were incu-
bated in blocking buffer (2% BSA in PBS) for 30 minutes
at room temperature or overnight at 4°C before transfer
to a moisture chamber. The coverslips were subse-
quently incubated with primary antibodies diluted in
blocking buffer for 90 minutes at room temperature or
overnight at 4°C (see Table 1 for list of primary anti-
bodies used) followed by 4 x 5 minutes wash in blocking
buffer and incubation in dark for 45 minutes with
fluorochrome-conjugated secondary antibodies (Alexa
Table 2 Primers applied in this study
Gene Direction Primer sequence (5′! 3′)
AURA (from [51]) Forward GCTGGAGAGCTTAAAATTGCAG
Reverse TTTTGTAGGTCTCTTGGTATGTG
GAPDH Forward GAAGGTGAAGGTCGGAGTC
Reverse GAAGATGGTGATGGGATTTC
GLI1 Forward GAACCCTTGGAAGGTGATATTC
Reverse GGCAGTCAGTTTCATACACAGAT
PTCH1 Forward ATCAGCCAGTTGACTAAACAG
Reverse GTTTCAGGCATGTAGTCGG
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from Invitrogen) diluted 1:600 in blocking buffer. Stain-
ing of F-actin with rhodamine-coupled phalloidin
(Invitrogen, 1:100) was done concomitantly with second-
ary antibody incubation. Hereafter, coverslips were
washed once in blocking buffer and briefly incubated
with DAPI. After washing in PBS, coverslips were
mounted on microscope slides in anti-fade mounting so-
lution, sealed with nail-polish and analyzed by micros-
copy as described for IHC. Cilia frequency was
determined by quantifying the number of ciliated and
non-ciliated cells of a minimum number of 130 cells for
each sample in at least three replicates.
SDS-PAGE and western blot analysis
SDS-PAGE and WB analysis was carried out essentially
as previously described [94]. Cell lysates were prepared
in boiling 0.1% SDS lysis buffer supplemented
with EDTA-free protease inhibitor cocktail (Roche,
Mannheim, Germany) and 1 mM Na3VO4. Lysates were
sonicated and centrifuged to precipitate cell debris, and
protein concentrations were measured using a DC Pro-
tein Assay (Bio-Rad, Hercules, California, USA) accord-
ing to the manufacturer’s instruction. Proteins were
separated under reducing and denaturing conditions by
SDS-PAGE) using 10% Bis-Tris precast gels (Invitrogen)
followed by electrophoretic transfer to nitrocellulose
membranes (Invitrogen). Membranes were incubated for
at least 30 minutes at room temperature or overnight at
4°C in 5% nonfat dry milk in Tris Buffered Saline with
Tween (5% milk-TBST; 10 mM Tris–HCl (pH 7.5),
120 mM NaCl, 0.1% Tween 20), before incubation with
primary antibodies for two hours at room temperature
or overnight at 4°C in moisture chambers (see Table 1
for antibodies used in WB analysis). Antibodies were
diluted in 5% milk-TBST as indicated below. Membranes
were washed several times in TBST followed by incuba-
tion with alkaline phosphatase-conjugated secondary
antibodies (Sigma) in 5% milk-TBST for 45 minutes at
room temperature. Blots were washed in TBST and pro-
tein bands were visualized using BCIP/NBT Phosphatase
Substrate (KPL, Gaithersburg, Maryland, USA). After air
drying, the developed blots were scanned and processed
with Adobe Photoshop version 6.0.
PCR and primers
In order to monitor the effect of serum starvation on gene
expression at the mRNA level RT-PCR was conducted on
wt and cancer OSE cells. Cells were grown in culture dishes
coated with 0.1% gelatin and serum depleted as described
above. RNA was purified using the NucleospinW RNA II kit
(Machery Nagel, Düren, Germany) according to the manu-
facturer’s instructions. RNA concentrations were deter-
mined using a GeneQuant pro spectrophotometer at260 nm. The RNA samples were stored at −80°C until use.
First-strand cDNA was synthesized in 40 μl reactions
according to instructions by Invitrogen using SuperScript™
II Reverse Transcriptase (400 units, Invitrogen), 250 ng ran-
dom primers (Invitrogen), recombinant RNasinW Ribo-
nuclease inhibitor (Promega, Madison, Wisconsin, USA)
and 1 μg total RNA; the cDNA samples were stored at
−20°C until use. PCR experiments were conducted in 25 μl
reactions according to instructions by Promega using the
Go TaqW DNA polymerase (Promega), 1 μg cDNA and
0.5 μM of each primer (Table 2). GAPDH was used as an
internal control. Annealing temperature and number of
amplification cycles were optimized for each primer set. For
each primer set-up one negative control without template
was included to ascertain the absence of primer-dimer and
genomic DNA amplifiation. After amplification, the PCR
products were separated by electrophoresis in a 2% agarose
gel containing ethidium bromide and visualized with UV
light. Images were obtained in a MultiDoc-It digital imaging
system (AH Diagnostis, Denmark).siRNA
AURA knockdown in SK-OV3 cells was performed using
ready-to-use custom synthesized siRNA (Thermo Scientific,
Lafayette, Colorado, USA) against human AURA (target se-
quence: GAACUUACUUCUUGGAUCA) or scrambled
oligonucleotides (mock) with similar GC content, both at
50 nM, and DharmaFECT transfection reagent (Thermo
Scientific) according to the manufacturer’s instructions.
Cells were transfected at 60% confluency. The day after
siRNA treatment, the cells were serum depleted as
described above and were used for experiments 72 hours
after siRNA treatment. Cilia quantifications were always ac-
companied by parallel WBs against AURA to verify
knockdown.
CHFR antibody production
For production of rabbit polyclonal antibodies specific
for human CHFR, a maltose binding protein (MBP)-
CHFR fusion protein was produced in Escherichia coli.
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of CHFR (Genbank ID AF170724.1) was amplified by
PCR from plasmid pEGFP-C1 (Clontech) containing
full-length CHFR coding sequence (kind gift from
Kenneth B. Schou, Danish Cancer Society, Copenhagen,
Denmark) using forward (5′-CAGAATTCATGGAGC
GGCCCGAG-3′) and reverse (5′-AAGGTCGACTTA
GTTTTTGAACCTTGTCTG-3′) primers with recogni-
tion sites for EcoRI and SalI, respectively, and Herculase
DNA polymerase from Stratagene (La Jolla, California,
USA). The PCR product was purified and cloned into
pMalC2 (New England Biolabs, Ipswich, Massachusetts)
using standard procedures and the ligated DNA trans-
formed into competent E. coli DH10α cells. Resulting
plasmids were control sequenced by Eurofins MWG Op-
eron. Production and purification of MBP-CHFR fusion
protein was carried out essentially as described previ-
ously [95] and purified MBP-CHFR fusion protein used
for polyclonal rabbit antibody production by Yorkshire
Bioscience Ltd (Heslington, York, United Kingdom). The
resulting CHFR rabbit antiserum was stored in saturated
ammonium sulfate solution at 4°C until use.
Statistical analysis
All experiments were repeated three or more times and
data are presented as representative individual experi-
ments or as mean values plus SD. The data were tested
for significance using one-way analysis of variance
(ANOVA) or Student’s t-test. The level of significance
was set at P < 0.05 (*), P < 0.01 (**), P < 0.001 (***).
Additional file
Additional file 1: Figure S1. Characterization of polyclonal antibody
against human CHFR WB analysis of lysates from hTERT-RPE1 cells serum-
starved for 48 hours (A, B), or NIH3T3 cells serum-starved for 24 hours (B).
The generated polyclonal rabbit antibody recognizes a single band on
the blots equivalent to the predicted size of CHFR (73 kDa for isoforms 1
and 2). In serum-starved hTERT-RPE1 cells stably expressing GFP-CHFR,
the antibody recognizes both endogenous CHFR and exogenous GFP-
CHFR (C). D, E) IFM analysis of endogenous CHFR (D) and exogenous
GFP-CHFR (E) in hTERT-RPE1 cells serum-starved for 48 hours and fixed
with mix-fix (D) or PFA-fix (E) (see Methods for details). Anti-acetylated α-
tubulin (Acet.tub) was used to detect primary cilia (arrows). In (D)
localization of endogenous CHFR is visualised with anti-CHFR, whereas
exogenous GFP-CHFR is detected with primary antibodies against GFP.
Abbreviations
Acet.tub, acetylated α-tubulin; ANOVA, analysis of variance; AURA, aurora A
kinase; BSA, bovine serum albumin; CHFR, checkpoint with forkhead-
associated and ring finger domains; CK18, cytokeratin 18; CK8, cytokeratin 8;
CT, centrin 2; DAPI, 4′,6-diamidino-2-phenylindole; DIC, differential
interference contrast microscopy; EOC, epithelial ovarian cancer; FBS, fetal
bovine serum; GFP, green fluorescent protein; Glu.tub, detyrosinated α-
tubulin; Hh, hedgehog; IFM, immunofluorescence microscopy;
IFT, intraflagellar transport; IgG, immunoglobulin G;
IHC, immunohistochemistry; LM, light microscopy; MBP, maltose binding
protein; OSE, ovarian surface epithelium; PBS, phosphate buffered saline;
PCNA, proliferating cell nuclear antigen; PCTN, pericentrin; PDGF, platelet-
derived growth factor; PDGFR, platelet-derived growth factor receptor;PFA, paraformaldehyde; p-RB, phosphorylated retinoblastoma protein;
PTCH1, patched-1; RT-PCR, reverse transcriptase polymerase chain reaction;
SMO, smoothened; TRIS, tris buffered saline with tween; WB, western blot;
wt, wild type; α-tub, α-tubulin.
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